[1]Locationinpatent:experimentalpartIsmaiel,AbdulkhaderM.;Gad,LailaM.;Ghareib,SalahA.;Bamanie,FaidaH.;Moustafa,MohamedA.[MedicinalChemistryResearch,2011,vol.20,#3,p.381-387]
3647-69-6
3240-94-6
76191-26-9
101251-23-4 | 2,5-Dichloro-4-methoxyaniline | AA00988P | MFCD16606083
1089709-08-9 | 3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]cyclobutanol | AA00999D | MFCD23105929
1186405-09-3 | 2-Chloro-3-iodo-4-(trifluoromethyl)pyridine | AA0099JN | MFCD12827836
1185301-70-5 | 3-(3-Phenylpropoxy)pyrrolidine hydrochloride | AA009A1T | MFCD09997067
12168-30-8 | AMMONIUM-D4 DEUTEROXIDE | AA009AN3 | MFCD00064511
135611-26-6 | 3-(2-Methylphenoxy)benzoic acid | AA009B0C | MFCD03840109
135186-78-6 | PYRIFTALID | AA009B4X | MFCD06201843
1307803-42-4 | JWH 018 4-hydroxyindole metabolite | AA009BKQ | MFCD18382134
1391194-64-1 | (2S)-Octyl-α-hydroxyglutarate | AA009BN5 | MFCD29045545
130551-49-4 | L-4-HYDROXYPHENYL-D4-ALANINE-2,3,3-D3 | AA009BT2 | MFCD01073923